Cytox Closes £1.5M Second Round Of Funding For Alzheimer’s Biomarker

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MANCHESTER, United Kingdom--(BUSINESS WIRE)--Cytox Ltd, (Cytox) a leading developer of assays for risk assessment and prediction of dementia, today announced the successful completion of a second round of funding, closing at £1.5M.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC